Chlordiazepoxide for imatinib-induced muscular cramps [1]

European Journal of Haematology

Volumn 77, Issue 6, 2006, Pages 538-

  Medeiros, Bruno C ^a   Lipton, Jeffrey H ^a  

^a PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BCR ABL PROTEIN; CALCIUM; CHLORDIAZEPOXIDE; CYTOCHROME P450 3A4; IMATINIB; MAGNESIUM; QUININE;

CHRONIC MYELOID LEUKEMIA; DRUG DOSE REDUCTION; ENZYME ACTIVITY; HUMAN; LABORATORY TEST; LETTER; MUSCLE CRAMP; PRIORITY JOURNAL; SUPPLEMENTATION; TREATMENT FAILURE;

ANTINEOPLASTIC AGENTS; CHLORDIAZEPOXIDE; CYTOCHROME P-450 ENZYME SYSTEM; FEMALE; GABA MODULATORS; HUMANS; INTERFERON-ALPHA; LEUKEMIA, MYELOID, CHRONIC; MIDDLE AGED; MUSCLE CRAMP; PIPERAZINES; PYRIMIDINES;

EID: 33750613137     PISSN: 09024441     EISSN: 16000609     Source Type: Journal    
DOI: 10.1111/j.1600-0609.2006.00742.x     Document Type: Letter

References (3)

1. DEININGER MW, O'BRIEN SG, FORD JM, DRUKER BJ. Practical management of patients with chronic myeloid leukemia receiving imatinib. J Clin Oncol 2003;21:1637-1647.
2. O'BRIEN SG, GUILHOT F, LARSON RA, ET AL. Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia. N Engl J Med 2003;348:994-1004.
3. DRUKER BJ, TALPAZ M, RESTA D, et al. Efficacy and safety of a specific inhibitor of the Bcr-Abl tyrosine kinase in chronic myeloid leukemia. N Engl J Med 2001;344:1031-1037.